FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991808032> ?p ?o ?g. }

• W1991808032 endingPage "431" @default.
• W1991808032 startingPage "420" @default.
• W1991808032 abstract "Abstract Traditional glioma chemotherapy with those second‐line drugs such as anthracyclines usually failed because they are inaccessible to blood–brain barrier (BBB) in tumor. In our study, we incorporated aclarubicin (ACL) into cationic albumin‐conjugated pegylated nanoparticle (CBSA‐NP–ACL) to determine its therapeutic potential of rats with intracranially implanted C6 glioma cells. When labeled with fluorescent probe, 6‐coumarin, CBSA‐NP was shown to accumulate much more in tumor mass than nanoparticle without conjugated CBSA (NP) 1 hr post intravenous injection, as well as better retention after 24 hr. Tumor drug concentration of CBSA‐NP–ACL displayed 2.6‐ and 3.3‐fold higher than that of NP–ACL and ACL solution 1 hr post injection, while 2.7 and 6.6‐fold higher after 24 hr, respectively. Moreover, using tumor microdialysis sampling, AUC 0–24 hr of free drug amount in tumor interstitium delivered by CBSA‐NP–ACL was about 2.0‐ and 2.7‐fold higher than that of NP–ACL and ACL solutions, respectively. When the tumor rat model was subjected to 4 cycles of 2 mg/kg of ACL in different formulations, a significant increase of median survival time was found in the group of CBSA‐NP–ACL compared with that of saline control animals, animals treated with NP–ACL and ACL solution. By terminal deoxynucleotidyl transferase‐mediated dUTP nick‐end‐labeling, CBSA‐NP–ACL can extensively make the tumor cell apoptosis. Histochemical evaluation by periodic acid Shiff staining and biochemical analysis depicted that the incorporation of ACL into CBSA‐NP reduced its toxicity to liver, kidney and heart. Besides, CBSA‐NP–ACL was not shown to open tight junction evaluated by BBB coculture. It was concluded that CBSA‐NP–ACL could have a therapeutic potential for treatment of glioma. © 2006 Wiley‐Liss, Inc." @default.
• W1991808032 created "2016-06-24" @default.
• W1991808032 creator A5000363531 @default.
• W1991808032 creator A5019570580 @default.
• W1991808032 creator A5030676810 @default.
• W1991808032 creator A5035830977 @default.
• W1991808032 creator A5089382753 @default.
• W1991808032 date "2006-10-25" @default.
• W1991808032 modified "2023-10-15" @default.
• W1991808032 title "Aclarubicin-loaded cationic albumin-conjugated pegylated nanoparticle for glioma chemotherapy in rats" @default.
• W1991808032 cites W1505719228 @default.
• W1991808032 cites W1512493964 @default.
• W1991808032 cites W1518840278 @default.
• W1991808032 cites W1526328115 @default.
• W1991808032 cites W1553061387 @default.
• W1991808032 cites W1692343830 @default.
• W1991808032 cites W1827539236 @default.
• W1991808032 cites W1909254787 @default.
• W1991808032 cites W1963991065 @default.
• W1991808032 cites W1968968207 @default.
• W1991808032 cites W1983090757 @default.
• W1991808032 cites W1985744874 @default.
• W1991808032 cites W1985858988 @default.
• W1991808032 cites W1986129921 @default.
• W1991808032 cites W1997080167 @default.
• W1991808032 cites W1999088373 @default.
• W1991808032 cites W1999204999 @default.
• W1991808032 cites W2001205271 @default.
• W1991808032 cites W2005542583 @default.
• W1991808032 cites W2009081910 @default.
• W1991808032 cites W2012405585 @default.
• W1991808032 cites W2014485768 @default.
• W1991808032 cites W2020915539 @default.
• W1991808032 cites W2032959148 @default.
• W1991808032 cites W2037468006 @default.
• W1991808032 cites W2040099927 @default.
• W1991808032 cites W2043513427 @default.
• W1991808032 cites W2068491059 @default.
• W1991808032 cites W2074667182 @default.
• W1991808032 cites W2074795427 @default.
• W1991808032 cites W2078348597 @default.
• W1991808032 cites W2079931597 @default.
• W1991808032 cites W2093793301 @default.
• W1991808032 cites W2095248480 @default.
• W1991808032 cites W2106437384 @default.
• W1991808032 cites W2108836709 @default.
• W1991808032 cites W2131041162 @default.
• W1991808032 cites W2133167758 @default.
• W1991808032 cites W2143629227 @default.
• W1991808032 cites W2164028234 @default.
• W1991808032 cites W2165288147 @default.
• W1991808032 cites W2169103384 @default.
• W1991808032 cites W2172341541 @default.
• W1991808032 cites W2266838684 @default.
• W1991808032 cites W2409295457 @default.
• W1991808032 cites W4298327683 @default.
• W1991808032 cites W59300367 @default.
• W1991808032 cites W66478222 @default.
• W1991808032 doi "https://doi.org/10.1002/ijc.22296" @default.
• W1991808032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17066446" @default.
• W1991808032 hasPublicationYear "2006" @default.
• W1991808032 type Work @default.
• W1991808032 sameAs 1991808032 @default.
• W1991808032 citedByCount "49" @default.
• W1991808032 countsByYear W19918080322012 @default.
• W1991808032 countsByYear W19918080322013 @default.
• W1991808032 countsByYear W19918080322014 @default.
• W1991808032 countsByYear W19918080322015 @default.
• W1991808032 countsByYear W19918080322016 @default.
• W1991808032 countsByYear W19918080322017 @default.
• W1991808032 countsByYear W19918080322018 @default.
• W1991808032 countsByYear W19918080322019 @default.
• W1991808032 countsByYear W19918080322020 @default.
• W1991808032 countsByYear W19918080322021 @default.
• W1991808032 crossrefType "journal-article" @default.
• W1991808032 hasAuthorship W1991808032A5000363531 @default.
• W1991808032 hasAuthorship W1991808032A5019570580 @default.
• W1991808032 hasAuthorship W1991808032A5030676810 @default.
• W1991808032 hasAuthorship W1991808032A5035830977 @default.
• W1991808032 hasAuthorship W1991808032A5089382753 @default.
• W1991808032 hasBestOaLocation W19918080321 @default.
• W1991808032 hasConcept C112613896 @default.
• W1991808032 hasConcept C141071460 @default.
• W1991808032 hasConcept C178790620 @default.
• W1991808032 hasConcept C185592680 @default.
• W1991808032 hasConcept C2776125364 @default.
• W1991808032 hasConcept C2776694085 @default.
• W1991808032 hasConcept C2778227246 @default.
• W1991808032 hasConcept C2780847677 @default.
• W1991808032 hasConcept C2781303535 @default.
• W1991808032 hasConcept C28406088 @default.
• W1991808032 hasConcept C50156730 @default.
• W1991808032 hasConcept C502942594 @default.
• W1991808032 hasConcept C521977710 @default.
• W1991808032 hasConcept C55493867 @default.
• W1991808032 hasConcept C71924100 @default.
• W1991808032 hasConcept C98274493 @default.
• W1991808032 hasConceptScore W1991808032C112613896 @default.

• next